RxDoctor Payments Data

Keith Dohogne

Physician Assistant · San Antonio, TXNPI 1548757099

Payments from drug & device makers

$2,631in general payments, 2019–2025

Across 175 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$922
  • AbbVie$618
  • Lilly USA, LLC$118
  • Optinose US, Inc.$110
  • IBSA Pharma Inc.$103
  • AstraZeneca$89
  • plus $670 from 17 others

What the payments were for

  • Food & beverage$2,631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,631 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide30$29,992
JardianceEmpagliflozin24$28,700
EliquisApixaban14$22,479
OzempicSemaglutide21$19,944
VascepaIcosapent Ethyl19$11,282
Rosuvastatin Calcium171$2,222
Atorvastatin Calcium197$2,049
Albuterol Sulfate HfaAlbuterol Sulfate77$1,983
Azelastine Hcl51$1,866
Levothyroxine Sodium206$1,701
Montelukast Sodium132$1,580
Fluticasone Propionate62$1,476
Tamsulosin Hcl90$1,419
Lisinopril206$1,210
Venlafaxine Hcl ErVenlafaxine Hcl41$1,197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$118$29,99230 claims
PfizerEliquis$33$22,47914 claims
Novo NordiskOzempic$922$19,94421 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$1,701206 claims
AbbVieSynthroid$618$45915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →